Strategies to optimize the use of erythropoietin and iron therapy in oncology patients

被引：5
|
作者：
Ford, PA
Mastoris, J
机构：
[1] Penn Hosp, Stem Cell Transplant Program, Philadelphia, PA 19106 USA
[2] Penn Hosp, Ctr Bloodless Med & Surg, Philadelphia, PA 19106 USA
来源：
TRANSFUSION | 2004年 / 44卷 / 12期
关键词：
D O I：
10.1111/j.0041-1132.2004.04169.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：15S / 25S
页数：11
相关论文
共 50 条
  • [41] Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin
    James B. Post
    Barry M. Wilkes
    Michael F. Michelis
    International Urology and Nephrology, 2006, 38 : 719 - 723
  • [42] Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin
    Post, James B.
    Wilkes, Barry M.
    Michelis, Michael F.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2006, 38 (3-4) : 719 - 723
  • [43] Erythropoietin and iron therapy for preterm infants - Reply
    Maier, RF
    Obladen, M
    Speer, CP
    JOURNAL OF PEDIATRICS, 1999, 134 (04): : 521 - 522
  • [44] Effective utilization of erythropoietin with intravenous iron therapy
    Bhandari, S
    Brownjohn, A
    Turney, J
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (01) : 73 - 78
  • [45] Erythropoietin and intravenous iron therapy in postpartum anaemia
    Wagstrom, Elle
    Akesson, Agneta
    Van Rooijen, Marianne
    Larson, Barbro
    Bremme, Katarina
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2007, 86 (08) : 957 - 962
  • [46] Use of a regional registry of chronic hepatitis patients to optimize antiviral therapy
    Tkachenko, L. I.
    Maleev, V. V.
    Sannikova, I. V.
    Titorenko, M. V.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (08) : 58 - 66
  • [47] Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
    Brancati, Valentina Urzi
    Scarpignato, Carmelo
    Minutoli, Letteria
    Pallio, Giovanni
    BIOMEDICINES, 2022, 10 (08)
  • [48] Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients
    Chang, CH
    Chang, CC
    Chiang, SS
    CLINICAL NEPHROLOGY, 2002, 57 (02) : 136 - 141
  • [49] Gastrointestinal Oncology - Therapy Strategies of the Future
    Schmid, Roland M.
    DRUG RESEARCH, 2021, 71 : S19 - S20
  • [50] Use of Pharmacogenetics to Optimize Immunosuppressive Therapy
    MacPhee, Iain A. M.
    THERAPEUTIC DRUG MONITORING, 2010, 32 (03) : 261 - 264
12345